InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-6.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Liddicoat John R, Chairman & CEO. Director active across 1 company, notably Medtronic plc. Aggregated, 7 disclosures have been recorded. History available since 28 May 2021. The latest transaction was filed on 29 July 2022 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
6,543 shares0Ordinary SharesSEC:0001127602-22-020222:0
139 shares@ US$122.980.0000% mcap0.5% of flowOrdinary SharesSEC:0001127602-21-028741:0
139 shares@ US$122.980.5% of flowOrdinary SharesSEC:0001127602-21-028741
3,258 shares@ US$131.310.0004% mcap12.3% of flowOrdinary SharesSEC:0001127602-21-023102:0
3,258 shares@ US$131.3112.3% of flowOrdinary SharesSEC:0001127602-21-023102
17,095 shares@ US$78.0037.2% of flowOrdinary SharesSEC:0001127602-21-018560
17,095 shares@ US$78.000.0011% mcap37.2% of flowOrdinary SharesSEC:0001127602-21-018560:0
7 of 7 declarations
About Liddicoat John R
John R. Liddicoat is the Chief Executive Officer of Medtronic plc, where he also serves as Executive Vice President and President of the Americas. With extensive experience in the healthcare sector, he is responsible for the strategic direction of the company, aiming to improve patient lives through innovative medical technologies.
